全文获取类型
收费全文 | 3013篇 |
免费 | 203篇 |
国内免费 | 23篇 |
学科分类
医药卫生 | 3239篇 |
出版年
2024年 | 5篇 |
2023年 | 31篇 |
2022年 | 79篇 |
2021年 | 122篇 |
2020年 | 78篇 |
2019年 | 117篇 |
2018年 | 104篇 |
2017年 | 67篇 |
2016年 | 100篇 |
2015年 | 83篇 |
2014年 | 141篇 |
2013年 | 141篇 |
2012年 | 261篇 |
2011年 | 224篇 |
2010年 | 118篇 |
2009年 | 120篇 |
2008年 | 170篇 |
2007年 | 165篇 |
2006年 | 150篇 |
2005年 | 153篇 |
2004年 | 167篇 |
2003年 | 146篇 |
2002年 | 102篇 |
2001年 | 27篇 |
2000年 | 23篇 |
1999年 | 23篇 |
1998年 | 20篇 |
1997年 | 25篇 |
1996年 | 16篇 |
1995年 | 19篇 |
1994年 | 12篇 |
1993年 | 12篇 |
1992年 | 13篇 |
1991年 | 12篇 |
1990年 | 16篇 |
1989年 | 10篇 |
1988年 | 16篇 |
1987年 | 24篇 |
1986年 | 17篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 7篇 |
1982年 | 10篇 |
1981年 | 5篇 |
1979年 | 12篇 |
1977年 | 6篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1966年 | 4篇 |
1964年 | 5篇 |
排序方式: 共有3239条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
David S. Ball D.O. Arnold C. Friedman David S. Hartman Paul D. Radecki Dina F. Caroline 《Urologic radiology》1986,8(1):46-48
This case report illustrates the magnetic resonance imaging (MRI) appearance of a typically asymptomatic renal oncocytoma as a homogeneous mass of medium signal with a stellate central region of decreased signal, representing the central scar. The MRI was correlated with computed tomography (CT), ultrasound (US), and gross pathologic appearance. The appearance of a central scar is not specific for oncocytoma and does not exclude renal cell carcinoma, as illustrated by a second case. 相似文献
5.
Background
Exercise has been recommended for improving global-well being in adults with fibromyalgia. However, no meta-analysis has determined the effects of exercise on global well-being using a single instrument and when analyzed separately according to intention-to-treat and per-protocol analyses. The purpose of this study was to fill that gap. 相似文献6.
7.
Selecting antibodies to detect HER2 overexpression by immunohistochemistry in invasive mammary carcinomas. 总被引:1,自引:0,他引:1
Agostinho Pinto Gouvêa Fernanda Milanezi Sandra Jean Olson Dina Leitao Fernando Carlos Schmitt Helenice Gobbi 《Applied immunohistochemistry & molecular morphology》2006,14(1):103-108
There is an increasing clinical demand for HER2 analysis in breast cancer, especially since the release of trastuzumab. The authors assessed the ability of immunohistochemistry to detect HER2 overexpression in invasive mammary carcinomas (IMC) using five antibodies. Paraffin-embedded samples of 86 IMCs (T2N0) were used to compare the immunohistochemical overexpression of HER2 using two polyclonal antibodies (HercepTest [DAKO] and A0485 [DAKO]) and three monoclonal antibodies (CB11 from two different laboratories, Biogenex and Novocastra, and 4D5 [Genentech]). All immunostainings were scored according to the FDA-approved HercepTest recommendations. The HercepTest-positive cases were compared with gene amplification by FISH (Oncor Inform, Ventana). The HercepTest was positive in 31 of the 86 cases (36.1%). The DAKO antibody A0485 was positive in 25 of the 66 (37.8%). Monoclonal antibody 4D5 was positive in only 15 of the 86 cases (17.4%). There was almost total agreement in results between the two CB11 antibodies: 25 of the 86 positive cases (29.1%). All cases positive for CB11 or 4D5 were HercepTest positive. Most of the HercepTest 2+ cases were negative when using either monoclonal antibody. FISH was positive in 19 of the 20 HercepTest 3+ cases and negative in 5 HercepTest 2+ cases. Three CB11-2+ cases showed no amplification by FISH. In three FISH-positive cases the immunohistochemistry showed no overexpression by all antibodies used. These findings suggest that immunohistochemistry may be used reliably as a primary methodology for evaluating HER2; however, the use of polyclonal antibodies may not be adequate to assess HER2 overexpression. CB11, regardless of the manufacturer (Biogenex or Novocastra), showed better concordance with FISH (kappa=0.83) than did the polyclonal antibodies. 相似文献
8.
9.
10.
Deborah Miller Dina Macdonald Ken Kolnacki Teresa Simek 《Nephrology nursing journal》2004,31(3):287-94; quiz 295-6
An important treatment goal for pediatric nephrology caregivers is the optimization of a child's capacity for normal growth and development. However, the physiologic and metabolic derangements associated with chronic kidney disease (CKD) significantly alter these processes, creating important challenges in the care of affected children. Evidence-based clinical practice guidelines support early recognition and treatment of CKD-related complications to improve growth and development and, ultimately, quality of life for children with this chronic condition. 相似文献